Katharina A.M. Lindner

机构：German Cancer Research Center, Heidelberg University, National Center for Tumor Diseases, Synimmune (Germany), Deutsches Konsortium für Translationale Krebsforschung · ORCID：0000-0002-2735-3266

发表论文 43 篇 · 总被引 507 次 · h-index 10

代表论文

• A H3K27M-targeted vaccine in adults with diffuse midline glioma (2023 · Nature Medicine · 被引 86)
• Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy (2024 · Nature Biotechnology · 被引 79)
• H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient (2024 · Science Advances · 被引 19)
• optiPRM: A Targeted Immunopeptidomics LC-MS Workflow With Ultra-High Sensitivity for the Detection of Mutation-Derived Tumor Neoepitopes From Limited Input Material (2024 · Molecular & Cellular Proteomics · 被引 13)
• IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer · 被引 3)
• Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (2026 · Nature Cancer · 被引 2)